Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases-Reference-Cited by-同舟云学术

Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases

Published:2020-04-06 Issue: Volume: Page:m1409
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Torjesen Ingrid

Publisher

BMJ

Subject

General Engineering

Reference6 articles.

1. NICE. COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community [NG163]. 3 Apr 2020. https://www.nice.org.uk/guidance/NG163.

2. NICE. COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community [NG165]. 3 Apr 2020. https://www.nice.org.uk/guidance/NG165.

3. NICE. COVID-19 rapid guideline: severe asthma [NG166]. 3 Apr 2020. https://www.nice.org.uk/guidance/NG166.

4. NICE. COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders [NG167]. 3 Apr 2020. https://www.nice.org.uk/guidance/NG167.

5. Covid-19: European drugs agency to review safety of ibuprofen

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID‐19 Pandemic;Arthritis Care & Research;2024-05-09

2. The prevalence of COVID-19 in patients with rheumatoid arthritis, multiple sclerosis, or systemic lupus erythematosus receiving biologic disease-modifying antirheumatic drugs;Immunopathologia Persa;2021-06-21

3. COVID-19: the winter lockdown strategy in five European nations;Journal of Risk Research;2021-03-05

4. Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19;Medicine;2021-02-12

5. Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19;Frontiers in Immunology;2021-02-08